Posted by Michael Wonder on 06 Dec 2019
Pharmacy chains sue Bausch Health, other drug makers for overcharging for diabetes drug
3 December 2019 - Three pharmacy chains, including Walgreens Boots Alliance, have filed a lawsuit against drugmakers Bausch Health, Assertio Therapeutics and Lupin, seeking damages for overcharging for Bausch’s diabetes drug Glumetza.
The lawsuit, filed on Monday, alleges that Assertio and Lupin struck a deal with units of Bausch to delay the entry of their generic versions of Glumetza and allowed the companies to “maintain a monopoly” in the sale of the branded drug and its generic copies.
